FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387270129> ?p ?o ?g. }

• W4387270129 abstract "Background: Morbidity and mortality from COVID-19 largely stem from a severe systemic inflammatory response. As such, medications with anti-inflammatory properties such as statins may have protective effects in COVID-19 patients. The purpose of our study was to determine whether in-hospital statin use was associated with lower morbidity or mortality in patients hospitalized with COVID-19. Methods: We conducted a two-center retrospective study of 692 adult patients hospitalized from March 2020 to October 2021 with COVID-19 confirmed by RT-PCR. Groups were stratified based on in-hospital statin use. Baseline characteristics, biomarkers, and in-hospital outcomes were described. A multivariate regression model was used to estimate the association of the primary outcome of interest with in-hospital statin use. Statin use was defined as any dose of atorvastatin, rosuvastatin, simvastatin, pravastatin, or fluvastatin. Statistical analyses were performed using SPSS 28. Results: Statin use was present in 45.7% (315/692) of patients. These patients were older (68 vs. 62 years old, p<0.001) and had higher rates of hyperlipidemia (31.9% vs. 16.3%, p<0.001), hypertension (78.7% vs. 54.9%, p<0.001), type 2 diabetes (50.2% vs. 31.5%, p<0.001), coronary artery disease (21.9% vs. 6.4%, p<0.001), heart failure (19.4% vs. 7.5%, p<0.001), and chronic kidney disease (16.8% vs. 5.1%, p<0.001). There was no difference in levels of low-density lipoprotein or inflammatory markers (D-dimer, CRP, and ferritin) between groups. However, patients with in-hospital statin use were less often treated with remdesivir (53.8% vs 61.3%, p=0.03), corticosteroids (71.8% vs 77.9%, p=0.04), or tocilizumab (10.4% vs 18.9%, p=0.001). Patients with in-hospital statin use had shorter length of stay (18 vs. 21 days, p<0.001) and lower adjusted odds of intubation (0.65 [0.46-0.92], p=0.01). There was no difference in all-cause mortality. Conclusion: COVID-19 patients treated with in-hospital statin therapy had more cardiovascular risk factors and received less treatment for COVID-19, yet they had shorter length of stay and lower odds of intubation. In-hospital statin use was not associated with lower risk of mortality." @default.
• W4387270129 created "2023-10-03" @default.
• W4387270129 creator A5012531674 @default.
• W4387270129 creator A5018836221 @default.
• W4387270129 creator A5072215818 @default.
• W4387270129 date "2023-05-01" @default.
• W4387270129 modified "2023-10-03" @default.
• W4387270129 title "Abstract 420: In-hospital Statin Use Is Not Associated With Lower Mortality In Patients Hospitalized With Covid-19" @default.
• W4387270129 doi "https://doi.org/10.1161/atvb.43.suppl_1.420" @default.
• W4387270129 hasPublicationYear "2023" @default.
• W4387270129 type Work @default.
• W4387270129 citedByCount "0" @default.
• W4387270129 crossrefType "journal-article" @default.
• W4387270129 hasAuthorship W4387270129A5012531674 @default.
• W4387270129 hasAuthorship W4387270129A5018836221 @default.
• W4387270129 hasAuthorship W4387270129A5072215818 @default.
• W4387270129 hasConcept C126322002 @default.
• W4387270129 hasConcept C134018914 @default.
• W4387270129 hasConcept C167135981 @default.
• W4387270129 hasConcept C17923572 @default.
• W4387270129 hasConcept C2776329913 @default.
• W4387270129 hasConcept C2776839432 @default.
• W4387270129 hasConcept C2777482532 @default.
• W4387270129 hasConcept C2778163477 @default.
• W4387270129 hasConcept C2778213512 @default.
• W4387270129 hasConcept C2778417548 @default.
• W4387270129 hasConcept C2778653478 @default.
• W4387270129 hasConcept C2779091943 @default.
• W4387270129 hasConcept C2779519902 @default.
• W4387270129 hasConcept C2780499067 @default.
• W4387270129 hasConcept C555293320 @default.
• W4387270129 hasConcept C71924100 @default.
• W4387270129 hasConceptScore W4387270129C126322002 @default.
• W4387270129 hasConceptScore W4387270129C134018914 @default.
• W4387270129 hasConceptScore W4387270129C167135981 @default.
• W4387270129 hasConceptScore W4387270129C17923572 @default.
• W4387270129 hasConceptScore W4387270129C2776329913 @default.
• W4387270129 hasConceptScore W4387270129C2776839432 @default.
• W4387270129 hasConceptScore W4387270129C2777482532 @default.
• W4387270129 hasConceptScore W4387270129C2778163477 @default.
• W4387270129 hasConceptScore W4387270129C2778213512 @default.
• W4387270129 hasConceptScore W4387270129C2778417548 @default.
• W4387270129 hasConceptScore W4387270129C2778653478 @default.
• W4387270129 hasConceptScore W4387270129C2779091943 @default.
• W4387270129 hasConceptScore W4387270129C2779519902 @default.
• W4387270129 hasConceptScore W4387270129C2780499067 @default.
• W4387270129 hasConceptScore W4387270129C555293320 @default.
• W4387270129 hasConceptScore W4387270129C71924100 @default.
• W4387270129 hasIssue "Suppl_1" @default.
• W4387270129 hasLocation W43872701291 @default.
• W4387270129 hasOpenAccess W4387270129 @default.
• W4387270129 hasPrimaryLocation W43872701291 @default.
• W4387270129 hasRelatedWork W138064960 @default.
• W4387270129 hasRelatedWork W1999506027 @default.
• W4387270129 hasRelatedWork W2074324898 @default.
• W4387270129 hasRelatedWork W2100240490 @default.
• W4387270129 hasRelatedWork W2605564895 @default.
• W4387270129 hasRelatedWork W2904158935 @default.
• W4387270129 hasRelatedWork W4243799561 @default.
• W4387270129 hasRelatedWork W4360602578 @default.
• W4387270129 hasRelatedWork W4367331482 @default.
• W4387270129 hasRelatedWork W71995819 @default.
• W4387270129 hasVolume "43" @default.
• W4387270129 isParatext "false" @default.
• W4387270129 isRetracted "false" @default.
• W4387270129 workType "article" @default.